Español
Questions About Cancer? 1-800-4-CANCER
  • Email

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-12 of 12 for your search:
Drug:  epratuzumab
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UCLA-0009041, IM-T-hLL2-07, UCLA-BB-IND-7124, NCI-G01-2004, NCT00022685

2.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: Not specified
Sponsor: Pharmaceutical / Industry
Protocol IDs: UNMC-289-97, IM-h-LL2-01, NCI-V97-1353

3.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 2 to 31
Sponsor: NCI, Other
Protocol IDs: ADVL04P2, NCI-2011-01624, COG-ADVL04P2, CDR0000396777, U10CA098543, NCT00098839

4.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 16 to 65
Sponsor: Other
Protocol IDs: 6125, NCT01279707

5.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: BRD 08/12-H, NCT01354457

6.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UCLA-0201056, AMGEN-AMG-412-159, NCI-G02-2094, NCT00042913

7.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UCLA-0109058, AMGEN-20010138, NCT00054379

8.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000459932, NCCTG-N0489, N0489, NCT00301821

9.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000572604, U10CA031946, CALGB-50701, NCT00553501

10.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 16 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000649725, S0910, U10CA032102, SWOG-S0910, NCT00945815

11.

Phase: Phase I
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: UCHSC-91264, NCI-V91-0216

12.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: LYMNHL0031, 200114861, 77550, CA09287, CA111827, NCT00398372
New Search